1 of 1
Story summary
- Researchers at the University of Waterloo in Ontario are developing cancer treatment using Clostridium sporogenes.
- They aim to enhance the bacterium's oxygen tolerance by adding a gene from a related species and using quorum sensing.
- The goal is for the bacteria to attack tumors from the inside out, with pre-clinical trials planned.
- Recent reports show that 70% of cancer patients in America live five years or more post-diagnosis.
